Immunoglobulins in Multiple Myeloma Patients Receiving a BCMA-Directed T Cell Engager
Clinical trial NCT07094048 · RECRUITING
Trial details
- NCT number
- NCT07094048
- Sponsor
- CHU de Quebec-Universite Laval
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-05
- Primary completion
- 2028-12-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.